107 related articles for article (PubMed ID: 11370767)
1. Gene therapy for human bypass grafts.
Mangi AA; Dzau VJ
Ann Med; 2001 Apr; 33(3):153-5. PubMed ID: 11370767
[TBL] [Abstract][Full Text] [Related]
2. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
Mann MJ; Whittemore AD; Donaldson MC; Belkin M; Conte MS; Polak JF; Orav EJ; Ehsan A; Dell'Acqua G; Dzau VJ
Lancet; 1999 Oct; 354(9189):1493-8. PubMed ID: 10551494
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
Alexander JH; Hafley G; Harrington RA; Peterson ED; Ferguson TB; Lorenz TJ; Goyal A; Gibson M; Mack MJ; Gennevois D; Califf RM; Kouchoukos NT;
JAMA; 2005 Nov; 294(19):2446-54. PubMed ID: 16287955
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor decoys for the prevention of vein bypass graft failure.
Mann MJ; Conte MS
Am J Cardiovasc Drugs; 2003; 3(2):79-85. PubMed ID: 14727934
[TBL] [Abstract][Full Text] [Related]
5. Excellent patency and growth potential of internal mammary artery grafts in pediatric coronary artery bypass surgery. New evidence for a "live" conduit.
Kitamura S; Seki T; Kawachi K; Morita R; Kawata T; Mizuguchi K; Kobayashi S; Fukutomi M; Nishii T; Kobayashi H
Circulation; 1988 Sep; 78(3 Pt 2):I129-39. PubMed ID: 3261649
[TBL] [Abstract][Full Text] [Related]
6. Early quantitative coronary angiography of saphenous vein grafts for coronary artery bypass grafting harvested by means of open versus endoscopic saphenectomy: a prospective randomized trial.
Perrault LP; Jeanmart H; Bilodeau L; Lespérance J; Tanguay JF; Bouchard D; Pagé P; Carrier M
J Thorac Cardiovasc Surg; 2004 May; 127(5):1402-7. PubMed ID: 15115999
[TBL] [Abstract][Full Text] [Related]
7. Towards the prevention of vein graft failure.
Mehta D; Izzat MB; Bryan AJ; Angelini GD
Int J Cardiol; 1997 Dec; 62 Suppl 1():S55-63. PubMed ID: 9464585
[TBL] [Abstract][Full Text] [Related]
8. Effect of coronary artery bypass grafting on native coronary artery stenosis. Comparison of internal thoracic artery and saphenous vein grafts.
Hamada Y; Kawachi K; Yamamoto T; Nakata T; Kashu Y; Watanabe Y; Sato M
J Cardiovasc Surg (Torino); 2001 Apr; 42(2):159-64. PubMed ID: 11292927
[TBL] [Abstract][Full Text] [Related]
9. The effects of on-pump and off-pump coronary artery bypass grafting on intraoperative graft flow in arterial and venous conduits defined by a flow/pressure ratio.
Balacumaraswami L; Abu-Omar Y; Selvanayagam J; Pigott D; Taggart DP
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):533-9. PubMed ID: 18329465
[TBL] [Abstract][Full Text] [Related]
10. Effects of atrial fibrillation on coronary artery bypass graft flow.
Shin H; Hashizume K; Iino Y; Koizumi K; Matayoshi T; Yozu R
Eur J Cardiothorac Surg; 2003 Feb; 23(2):175-8. PubMed ID: 12559339
[TBL] [Abstract][Full Text] [Related]
11. Evolution of complete arterial grafting. For coronary artery disease.
Buxton BF; Fuller JA; Tatoulis J
Tex Heart Inst J; 1998; 25(1):17-23. PubMed ID: 9566058
[TBL] [Abstract][Full Text] [Related]
12. Coronary bypass surgery with internal-thoracic-artery grafts--effects on survival over a 15-year period.
Cameron A; Davis KB; Green G; Schaff HV
N Engl J Med; 1996 Jan; 334(4):216-9. PubMed ID: 8531997
[TBL] [Abstract][Full Text] [Related]
13. [Problems and prevention in using arterial grafts for coronary artery bypass grafting].
Yasuura K; Matsuura A; Maseki T; Sawazaki M; Takagi Y; Abe T; Seki A; Ichihara T; Hoshino M; Asakura T
Kyobu Geka; 1992 Jul; 45(8 Suppl):725-7. PubMed ID: 1405153
[TBL] [Abstract][Full Text] [Related]
14. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
Ehsan A; Mann MJ; Dell'Acqua G; Dzau VJ
J Thorac Cardiovasc Surg; 2001 Apr; 121(4):714-22. PubMed ID: 11279413
[TBL] [Abstract][Full Text] [Related]
15. Arterial revascularization in primary coronary artery bypass grafting: Direct comparison of 4 strategies--results of the Stand-in-Y Mammary Study.
Nasso G; Coppola R; Bonifazi R; Piancone F; Bozzetti G; Speziale G
J Thorac Cardiovasc Surg; 2009 May; 137(5):1093-100. PubMed ID: 19379973
[TBL] [Abstract][Full Text] [Related]
16. Coronary-coronary bypass graft: an arterial conduit-sparing procedure.
Nottin R; Grinda JM; Anidjar S; Folliguet T; Detroux M
J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1223-30. PubMed ID: 8911318
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative transfection of vein grafts with the NFkappaB decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia.
Shintani T; Sawa Y; Takahashi T; Matsumiya G; Matsuura N; Miyamoto Y; Matsuda H
Ann Thorac Surg; 2002 Oct; 74(4):1132-7; discussion 1137-8. PubMed ID: 12400757
[TBL] [Abstract][Full Text] [Related]
18. Molecular engineering of vein bypass grafts.
Conte MS
J Vasc Surg; 2007 Jun; 45 Suppl A():A74-81. PubMed ID: 17544027
[TBL] [Abstract][Full Text] [Related]
19. Preoperative factors predicting saphenous vein graft occlusion in coronary artery bypass grafting: a multivariate analysis.
Malinska A; Podemska Z; Perek B; Jemielity M; Buczkowski P; Grzymislawska M; Sujka-Kordowska P; Nowicki M
Histochem Cell Biol; 2017 Oct; 148(4):417-424. PubMed ID: 28478589
[TBL] [Abstract][Full Text] [Related]
20. The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting.
Dreifaldt M; Mannion JD; Bodin L; Olsson H; Zagozdzon L; Souza D
Ann Thorac Surg; 2013 Jul; 96(1):105-11. PubMed ID: 23684156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
